Ketamine was developed 50 years ago and has been used as an anesthetic, during surgery, since the 1960s. Recent research demonstrates that Ketamine is rapidly effective, within hours, in treating multiple mental and physical conditions.
Ketamine has been found to effectively treat the following conditions, many of which have not been receptive to conventional treatment approaches: both unipolar and bipolar depression, including suicidal ideation, Post-Traumatic Stress Disorder (PTSD), anxiety, Complex Regional Pain Syndrome (CRPS), Reflexive Sympathetic Dystrophy (RSD), Fibromyalgia, migraines and small fiber neuropathy.
Chronic pain, depression and anxiety damage the areas of the brain responsible for memory, learning and higher-order thinking. These traumatized and irritated nerve endings are responsible for depressed mood, anxiety and send pain signals directly to the brain.
Ketamine promotes the biochemicals necessary to repair this damage, within hours, by creating new pathways with new nerve endings. These new nerve endings act as highways for healthy communication to occur with the brain. The process essentially reboots our brain and central pain centers, providing long-term relief. Therefore, Ketamine may provide lasting relief from depression. This process and effects act in contrast to the effects of opiates on the body; opiates have been shown to increase pain sensitivity in patients, over time.
Ketamine IV therapy is often used when other treatment modalities have failed. For patients suffering from chronic pain,
moderate to severe depression, PTSD or anxiety, completing IV therapy requires a patient to undergo a series of low dose
Generally, treatment is well-tolerated, however; certain patients may experience side-effects, some of which may require
discontinuation of therapy. Though recent research shows promise for the use of Ketamine for the above listed conditions;
currently, the FDA would consider the use of Ketamine for anything other than an anesthetic as off-label prescribing.